Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 15, 2021
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
[ Mon, Nov 15th 2021
] - WOPRAI
Joseph Schwartz Maintained (BMRN) at Buy with Increased Target to $112 on, Nov 15th, 2021
Joseph Schwartz of SVB Leerink, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $108 to $112 on, Nov 15th, 2021.
Joseph has made no other calls on BMRN in the last 4 months.
There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $88 on, Thursday, July 29th, 2021
These are the ratings of the 2 analyists that currently disagree with Joseph
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $100 on, Thursday, October 28th, 2021
- Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $96 on, Thursday, September 9th, 2021
